GlassScriptPhysician profile
Dona Sue Baker
NPI 1649804378
$1,440.44
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $460 · 2022: $962 · 2023: $18.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $296.70 | 2021-2022 | |
| Janssen Biotech, INC. | $238.72 | 2021-2023 | Imbruvica, Darzalex |
| Daiichi Sankyo INC. | $169.52 | 2021-2022 | |
| Lilly USA, LLC | $141.47 | 2022 | |
| Amgen INC. | $115.47 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $64.96 | 2021-2022 | |
| Pfizer INC. | $62.69 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $46.28 | 2021-2022 | |
| Beigene USA, INC. | $41.64 | 2022 | |
| Celgene Corporation | $30.77 | 2021 | |
| Cti Biopharma Corp. | $27.01 | 2022 | |
| Genzyme Corporation | $21.45 | 2022 | |
| Adaptive Biotechnologies Corporation | $21.43 | 2022 | |
| Puma Biotechnology, INC. | $19.13 | 2022 | |
| G1 Therapeutics, INC. | $18.92 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $18.76 | 2022 | |
| Mylan Institutional INC. | $18.67 | 2022 | |
| Foundation Medicine, INC. | $16.51 | 2022 | |
| Astellas Pharma US INC | $15.20 | 2022 | |
| Jazz Pharmaceuticals INC. | $14.48 | 2022 | |
| Tg Therapeutics, INC. | $14.01 | 2021 | |
| Glaxosmithkline, LLC. | $13.93 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dona Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.